GH-RH antagonist (MZ-4-71) inhibits VEGF secretion and proliferation of murine endothelial cells

A. Siejka, H. Ławnicka, J. Komorowski, Andrew V Schally, T. Stȩpień, R. Krupiński, H. Stȩpień

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Angiogenesis plays a key role in solid tumor formation, invasiveness and metastasis. Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen that is necessary in the process of neovascularisation. Antagonists of growth hormone-releasing hormone (GH-RH) have been shown to suppress both in vivo and in vitro growth and metastasis of many human cancer cell lines. The mechanisms that mediate the antitumorigenic actions of these antagonists involve direct and indirect pathways, but are not completely elucidated. We have examined the effect of GH-RH antagonist MZ-4-71 on proliferation activity and VEGF release from cultured murine endothelial cells HECa10 in vitro. MZ-4-71 at 10-8 to 10-6 M concentrations inhibited the proliferative activity of cultured cells and suppressed the release of VEGF into supernatants of 72 h endothelial cell cultures. To our knowledge this is the first study reporting antiangiogenic properties of GH-RH antagonists.

Original languageEnglish
Pages (from-to)2473-2479
Number of pages7
JournalLife Sciences
Volume72
Issue number22
DOIs
StatePublished - Apr 18 2003
Externally publishedYes

Fingerprint

Hormone Antagonists
Growth Hormone-Releasing Hormone
Endothelial cells
Vascular Endothelial Growth Factor A
Endothelial Cells
Cells
Neoplasm Metastasis
Mitogens
Cell culture
Tumors
Cultured Cells
Neoplasms
Cell Culture Techniques
Cell Line
Growth
MZ 4-71
In Vitro Techniques

Keywords

  • Angiogenesis
  • GH-RH analogs
  • Proliferation
  • VEGF

ASJC Scopus subject areas

  • Pharmacology

Cite this

Siejka, A., Ławnicka, H., Komorowski, J., Schally, A. V., Stȩpień, T., Krupiński, R., & Stȩpień, H. (2003). GH-RH antagonist (MZ-4-71) inhibits VEGF secretion and proliferation of murine endothelial cells. Life Sciences, 72(22), 2473-2479. https://doi.org/10.1016/S0024-3205(03)00164-4

GH-RH antagonist (MZ-4-71) inhibits VEGF secretion and proliferation of murine endothelial cells. / Siejka, A.; Ławnicka, H.; Komorowski, J.; Schally, Andrew V; Stȩpień, T.; Krupiński, R.; Stȩpień, H.

In: Life Sciences, Vol. 72, No. 22, 18.04.2003, p. 2473-2479.

Research output: Contribution to journalArticle

Siejka, A, Ławnicka, H, Komorowski, J, Schally, AV, Stȩpień, T, Krupiński, R & Stȩpień, H 2003, 'GH-RH antagonist (MZ-4-71) inhibits VEGF secretion and proliferation of murine endothelial cells', Life Sciences, vol. 72, no. 22, pp. 2473-2479. https://doi.org/10.1016/S0024-3205(03)00164-4
Siejka, A. ; Ławnicka, H. ; Komorowski, J. ; Schally, Andrew V ; Stȩpień, T. ; Krupiński, R. ; Stȩpień, H. / GH-RH antagonist (MZ-4-71) inhibits VEGF secretion and proliferation of murine endothelial cells. In: Life Sciences. 2003 ; Vol. 72, No. 22. pp. 2473-2479.
@article{eca550072f7540feb1fd81e6e82852b6,
title = "GH-RH antagonist (MZ-4-71) inhibits VEGF secretion and proliferation of murine endothelial cells",
abstract = "Angiogenesis plays a key role in solid tumor formation, invasiveness and metastasis. Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen that is necessary in the process of neovascularisation. Antagonists of growth hormone-releasing hormone (GH-RH) have been shown to suppress both in vivo and in vitro growth and metastasis of many human cancer cell lines. The mechanisms that mediate the antitumorigenic actions of these antagonists involve direct and indirect pathways, but are not completely elucidated. We have examined the effect of GH-RH antagonist MZ-4-71 on proliferation activity and VEGF release from cultured murine endothelial cells HECa10 in vitro. MZ-4-71 at 10-8 to 10-6 M concentrations inhibited the proliferative activity of cultured cells and suppressed the release of VEGF into supernatants of 72 h endothelial cell cultures. To our knowledge this is the first study reporting antiangiogenic properties of GH-RH antagonists.",
keywords = "Angiogenesis, GH-RH analogs, Proliferation, VEGF",
author = "A. Siejka and H. Ławnicka and J. Komorowski and Schally, {Andrew V} and T. Stȩpień and R. Krupiński and H. Stȩpień",
year = "2003",
month = "4",
day = "18",
doi = "10.1016/S0024-3205(03)00164-4",
language = "English",
volume = "72",
pages = "2473--2479",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "22",

}

TY - JOUR

T1 - GH-RH antagonist (MZ-4-71) inhibits VEGF secretion and proliferation of murine endothelial cells

AU - Siejka, A.

AU - Ławnicka, H.

AU - Komorowski, J.

AU - Schally, Andrew V

AU - Stȩpień, T.

AU - Krupiński, R.

AU - Stȩpień, H.

PY - 2003/4/18

Y1 - 2003/4/18

N2 - Angiogenesis plays a key role in solid tumor formation, invasiveness and metastasis. Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen that is necessary in the process of neovascularisation. Antagonists of growth hormone-releasing hormone (GH-RH) have been shown to suppress both in vivo and in vitro growth and metastasis of many human cancer cell lines. The mechanisms that mediate the antitumorigenic actions of these antagonists involve direct and indirect pathways, but are not completely elucidated. We have examined the effect of GH-RH antagonist MZ-4-71 on proliferation activity and VEGF release from cultured murine endothelial cells HECa10 in vitro. MZ-4-71 at 10-8 to 10-6 M concentrations inhibited the proliferative activity of cultured cells and suppressed the release of VEGF into supernatants of 72 h endothelial cell cultures. To our knowledge this is the first study reporting antiangiogenic properties of GH-RH antagonists.

AB - Angiogenesis plays a key role in solid tumor formation, invasiveness and metastasis. Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen that is necessary in the process of neovascularisation. Antagonists of growth hormone-releasing hormone (GH-RH) have been shown to suppress both in vivo and in vitro growth and metastasis of many human cancer cell lines. The mechanisms that mediate the antitumorigenic actions of these antagonists involve direct and indirect pathways, but are not completely elucidated. We have examined the effect of GH-RH antagonist MZ-4-71 on proliferation activity and VEGF release from cultured murine endothelial cells HECa10 in vitro. MZ-4-71 at 10-8 to 10-6 M concentrations inhibited the proliferative activity of cultured cells and suppressed the release of VEGF into supernatants of 72 h endothelial cell cultures. To our knowledge this is the first study reporting antiangiogenic properties of GH-RH antagonists.

KW - Angiogenesis

KW - GH-RH analogs

KW - Proliferation

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=0037453207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037453207&partnerID=8YFLogxK

U2 - 10.1016/S0024-3205(03)00164-4

DO - 10.1016/S0024-3205(03)00164-4

M3 - Article

C2 - 12650855

AN - SCOPUS:0037453207

VL - 72

SP - 2473

EP - 2479

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 22

ER -